Non-tuberculous slow-growing mycobacterial pulmonary infections in non-HIV-infected patients in south London

Abstract

M. kansasii was the most common NTM and its isolation was predictive of clinical disease. Compared with other studies, treatment with 3 agents had a similar rate of cure and did not appear to reduce the relapse rate of disease, but did increase the risk of side effects.

References

Page 1

	Year	Citations
Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999 Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society Thorax Pulmonary TuberculosisTuberculosis PreventionHealthcare-associated InfectionTuberculosisMicrobiology	2000	224
Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999 Francis Drobniewski Research Portal (King's College London) Pulmonary TuberculosisTuberculosis PreventionHealthcare-associated InfectionTuberculosisMicrobiology	2000	224
Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Eisaku Tanaka, Ryoichi Amitani, Akio Niimi, American Journal of Respiratory and Critical Care Medicine Computed TomographyDiagnosisPathologyMycobacterium Avium ComplexLung Tissue	1997	170
Nontuberculous Mycobacterial Pulmonary Infection in Immunocompetent Patients: Comparison of Thin-Section CT and Histopathologic Findings Yeon Joo Jeong, Kyung Soo Lee, Won‐Jung Koh, Radiology	2004	169
Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients M. Dailloux, M.L. Abalain, C. Laurain, European Respiratory Journal	2006	126
Thrice-Weekly Clarithromycin-Containing Regimen for Treatment of Mycobacterium kansasii Lung Disease: Results of a Preliminary Study David E. Griffith, Barbara A. Brown‐Elliott, Richard J. Wallace Clinical Infectious Diseases	2003	108
Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France C. Andréjak, F.-X. Lescure, Evelina Pukenytė, Thorax	2008	100
Pulmonary Mycobacterium kansasii Infection in Israel, 1999–2004 David Shitrit, Gerry L. Baum, Rachel Priess, CHEST Journal Respiratory InfectionInfectious Respiratory DiseasePulmonary MedicineMicrobiologyInfection Control	2006	88
Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society. J Banks, Ian Campbell, Drs Agnew, Thorax	1994	77
Pulmonary disease caused by<i>M. malmoense</i>in HIV negative patients: 5‐yr follow-up of patients receiving standardised treatment European Respiratory Journal Advanced Lung DiseaseTuberculosis PreventionHiv Negative PatientsMycobacterium MalmoenseClinical Epidemiology	2003	60

Page 1